Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Arista Networks is already the quiet backbone for cloud and AI data centers. With AI-driven networking demand accelerating, favorable technicals, strong cash generation and a still-deep pipeline of customers, ANET looks set for another leg higher. This is a tactical long: entry $204, stop $186, target $240, horizon: long term (180 trading days).
Energy Transfer (ET) has pulled back on reports of a Project Jupiter snag, but fundamentals and valuation argue this is a buying opportunity. With $5.2B in free cash flow, an EV/EBITDA of ~8.0 and a 6.7% yield, ET offers income and upside if medium-term project and demand catalysts play out. Trade plan: enter $19.50, stop $18.00, target $24.00 - mi…
Sprouts Farmers Market is trading near its 52-week low while fundamentals - high gross margins, strong ROE and healthy free cash flow - argue for a re-rating. Technicals are oversold and activist buying has increased investor attention. This trade targets a mid-term recovery into the mid-$80s with a clear stop to limit downside.
Alphabet's proprietary TPU infrastructure, healthy free cash flow and durable ad franchise make a compelling long trade after a pullback. We lay out an entry at $338.84, stop at $315.00 and a $390.00 target over a 180 trading-day horizon, with clear catalysts and risks tied to AI hardware competition, ad demand and regulatory pressure.
Palantir's AI Platform (AIP) has moved from pilot phase to tangible revenue acceleration. With management guiding full-year revenue north of $8.0B (82% growth) and U.S. commercial revenue expected above $3.4B (134% growth), the next leg higher looks driven by repeatable sales, strong cash generation, and improving technicals. This trade idea offers…
Western Digital is generating robust free cash flow, showing double-digit revenue growth and returning capital to shareholders even as macro sentiment stumbles. With a market cap near $164B, FCF of $3.51B, and solid guidance into fiscal Q1 2027, this trade targets upside from current levels while maintaining a clear stop for rising macro risk.
MGP Ingredients (MGPI) looks like one of the cheapest names in the distressed distillery group: sub-$275M market cap, P/B ~0.46, and EV/EBITDA ~7.1. The stock is deeply oversold with an RSI near 21 and a 52-week low at $12.50. This trade targets a mid-term rebound while acknowledging material legal and demand risks that justify a tight stop and mod…
Kimberly-Clark (KMB) offers a 5.2% yield, reasonable valuation (P/E ~16.8) and $1.82B in free cash flow. The near-term Kenvue acquisition raises leverage and execution risk, but the stock's discounted level, strong cash conversion and upcoming dividend payout make a dividend-and-safe-haven long trade attractive for patient income-focused investors …
POSCO Holdings trades at $55.82 with a $17.8B market cap, cheap book value and a modest yield. Recent corporate moves and accelerating demand for high‑strength steel and EV battery materials justify a mid‑term long. Enter $55.82, target $68.00, stop $50.00; horizon: mid term (45 trading days).
Visa is my preferred pick in the payments duopoly. Strong return on equity, $21B in free cash flow, and predictable volume growth make Visa a better risk-reward than Mastercard for a 180-trading-day trade. Enter at $366.65, target $385.00, stop $345.00.
Cullinan Therapeutics presents a tactical long after a market-led pullback. CLN-978, a T-cell engaging program aimed at autoimmune targets, retains clinical upside and a tolerability profile that could re-rate the stock if upcoming readouts or partnering interest materialize. This trade outlines entry, stop, and target prices with catalysts and bal…
Beam Therapeutics (BEAM) has tangible clinical progress in AATD and multiple programs moving into pivotal work. With a market cap near $2.5B, a supportive balance sheet, and visible catalysts, we prefer a mid-term long swing to capture follow-through from clinical data and investor rotation into gene editing—while protecting capital with a defined …
Nu Holdings has turned explosive user growth into real profitability and cash generation. At roughly $59 billion market cap and trading near $12.25, the stock prices in slower expansion than the company is delivering. This trade idea outlines a long entry, targets and risks for a long-term (180 trading days) position that backs the thesis with rece…
Gold Fields looks like a tactical long after recent weakness: a successful ramp at Salares Norte should underpin production and cash flow, valuation is reasonable at a $31.2B market cap and 8.2x P/E, and the stock is technically oversold (RSI ~30). That said, government/regulatory risk at Tarkwa and potential M&A/capital-discipline questions could …
Porsche Automobil Holding Pfd (POAHF) is trading around $28.86 and remains below all major short-term moving averages while short interest has climbed sharply to 774,358 shares as of 09/15/2026. Technical momentum is bearish and recent high short-volume days show active downside conviction. This trade proposes a measured short with a mid-term horiz…
Rubrik posted a string of beat-and-raise quarters, stronger-than-expected ARR growth and a material free cash flow print. With enterprise security budgets shifting to subscription backup and cyber recovery, Rubrik is positioned to convert revenue growth into durable free cash flow. This trade idea outlines a tactical long entry at $113.10 with a $1…
KLA is a market leader in semiconductor process control and inspection. Recent pullbacks offer a time-limited entry: a mid-term (45 trading days) long that aims to capture upside from AI-related process intensity and a growing advanced-packaging revenue stream, while respecting premium valuation with a disciplined stop.
Enterprise Products Partners (EPD) is a buy here. The pipeline giant generates meaningful free cash flow ($3.46B trailing) and trades at ~11x EV/EBITDA and a 6.1% yield. With $6.5B of projects under construction, low leverage and decades of payout increases, EPD has the balance-sheet capacity to accelerate distributions. Technicals are oversold and…
Intel offers real business momentum and improving cash generation, but the stock's run-up has compressed the margin for error. This trade aims to capture continued DCAI strength while limiting downside if sentiment reverts.
Nike is trading like a legacy retailer rather than a market-leading brand. With a market cap near $54B, a 4.6% dividend yield, positive free cash flow and a management plan to stabilize inventory and rebuild wholesale relationships, the stock offers an attractive risk-reward for investors willing to wait. This trade idea lays out an entry at $36.50…
Astellas' $315M deal and an advancing oncology and hepatitis delta program give Vir Biotechnology a clearer path to value realization. With a $1.78B market cap, a healthy cash cushion and upcoming Phase 3 readouts, the setup favors a mid-term long trade. Entry $10.75, target $14.00, stop $9.00; horizon: mid term (45 trading days).
Oracle is trading roughly 59% below its 52-week high despite strong cloud revenue growth, a $600B+ backlog and improving profitability. The market is punishing heavy capex and negative free cash flow today; that creates a tactical long opportunity around $132.72 with defined stops and staged targets across 10- to 180-trading-day horizons.
Shares of Boston Scientific (BSX) sit nearer the 52-week low after a pronounced pullback from the $105 peak. Fundamentals remain intact - $3.62B in free cash flow, a conservative debt-to-equity of 0.51 and a P/E near 17.5 - and recent negative sentiment appears overstated versus the firm's product pipeline and cash generation. This trade idea outli…
Bloom Energy (BE) sits at the intersection of structural demand from AI data centers and a massive order backlog. The stock trades at a premium, but the company is generating free cash flow and has a $20 billion backlog that could drive outsized revenue growth if execution holds. This trade idea offers an entry, precise targets, and a stop — a dire…
Suncor (SU) is benefitting from strong downstream margins and recovering upstream volumes, producing a near-term cash-flow tailwind that can fund debt paydown and shareholder returns. The company trades at roughly $80.6B market cap with a forward feel of value (P/E ~12.6) while still carrying legacy capital intensity and volatile free cash flow. Th…
